Namilumab (anti-GM-CSF)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Natalizumab (anti-ITGA4)
109.00 ¥ 109.00 ¥ 109.0 CNY
Nimotuzumab (anti-EGFR)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Ocrelizumab (anti-CD20)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Ontamalimab (anti-MADCAM1)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Opicinumab (anti-LINGO1)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
OSE-127
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Osocimab (anti-Factor XI)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Otilimab (anti-GM-CSF)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Ozoralizumab (anti-TNF-alpha&HSA)
159.00 ¥ 159.00 ¥ 159.0 CNY
Pascolizumab (anti-IL-4)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Pateclizumab (anti-TNFb)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
perenostobart
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
PF-07062119
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Pidilizumab (anti-PD-1)
229.00 ¥ 229.00 ¥ 229.0 CNY
PiN-21
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Plonmarlimab (anti-GM-CSF)
229.00 ¥ 229.00 ¥ 229.0 CNY
Plozalizumab (anti-CCR2)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Polatuzumab vedotin-piiq (anti-CD79b)
509.00 ¥ 509.00 ¥ 509.0 CNY
Quilizumab (anti-IgE)
199.00 ¥ 199.00 ¥ 199.0 CNY